Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{161321, author = {Dr. Ankita Thakur and Dr. Bhawana Sharma and Dr. Rupali}, title = {A REVIEW ARTICLE ON PUNARNAVASTHAK KWATH}, journal = {International Journal of Innovative Research in Technology}, year = {}, volume = {10}, number = {3}, pages = {268-274}, issn = {2349-6002}, url = {https://ijirt.org/article?manuscript=161321}, abstract = {In the era of modern technology, Ayurvedic pharmaceutical industries are demanding standardization at every step of processing pharmaceutical area. Kwath (decoction) Kalpna is the basic dosage for many other important dosage of formulations. Kwath Kalpana is the most considerable and mostly used form of the Ayurvedic pharmaceutical formulations. It have some disadvantages i.e. to certifying the quality control of the herbal ingredients. There are many drugs for Pandu in Ayurveda. But here in this review article I am going to describe the components of these drugs which are used in treatment of Pandu. These herbs in these drugs are having potential to treat the symptoms of Pandu. Punarnavasthak kwath is having hepatoprotective effect which help in treating Pandu roga. This drug has been taken from chakardatt udarroga chikitsa adhaya. These classical text describes the importance of these drugs in Hepatoprotective disorders. This review article is a attempt to describe the properties of this drug which are used in Pandu roga.}, keywords = {Kwath Kalpana, Kashya, Pandu, Punarnavasthak, Hepatoprotective}, month = {}, }
Cite This Article
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry